SE7607496L - Sett for bekempning av virusinfektioner - Google Patents

Sett for bekempning av virusinfektioner

Info

Publication number
SE7607496L
SE7607496L SE7607496A SE7607496A SE7607496L SE 7607496 L SE7607496 L SE 7607496L SE 7607496 A SE7607496 A SE 7607496A SE 7607496 A SE7607496 A SE 7607496A SE 7607496 L SE7607496 L SE 7607496L
Authority
SE
Sweden
Prior art keywords
virus infections
fighting
fighting virus
infections
virus
Prior art date
Application number
SE7607496A
Other languages
English (en)
Swedish (sv)
Inventor
B Eriksson
E Helgstrand
A Misiorny
G Stening
S-A Stridh
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20328354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE7607496(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Priority to SE7607496A priority Critical patent/SE7607496L/xx
Priority to US05/807,783 priority patent/US4215113A/en
Priority to DE2728685A priority patent/DE2728685C2/de
Priority to AU26505/77A priority patent/AU510809B2/en
Priority to IE1311/77A priority patent/IE45753B1/en
Priority to NLAANVRAGE7707235,A priority patent/NL180068C/xx
Priority to DK288877A priority patent/DK288877A/da
Priority to NO772299A priority patent/NO772299L/no
Priority to FI772030A priority patent/FI772030A/fi
Priority to AT0465477A priority patent/AT369014B/de
Priority to LU77666A priority patent/LU77666A1/xx
Priority to GB27464/77A priority patent/GB1585615A/en
Priority to CH808577A priority patent/CH641471A5/de
Priority to FR7720100A priority patent/FR2356424A1/fr
Priority to CA281,863A priority patent/CA1077848A/en
Priority to JP7797777A priority patent/JPS536428A/ja
Priority to BE178982A priority patent/BE856355A/xx
Publication of SE7607496L publication Critical patent/SE7607496L/xx
Priority to US05/971,931 priority patent/US4339445A/en
Priority to US06/404,295 priority patent/US4665062A/en
Priority to SG803/83A priority patent/SG80383G/en
Priority to HK289/84A priority patent/HK28984A/xx
Priority to US06/793,575 priority patent/US4771041A/en
Priority to MY125/85A priority patent/MY8500125A/xx
Priority to MX9203635A priority patent/MX9203635A/es
Priority to NL930053C priority patent/NL930053I2/nl
Priority to LU88310C priority patent/LU88310I2/fr
Priority to BG098492A priority patent/BG60834B2/bg
Priority to LV960278A priority patent/LV5791A4/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
SE7607496A 1976-07-01 1976-07-01 Sett for bekempning av virusinfektioner SE7607496L (sv)

Priority Applications (28)

Application Number Priority Date Filing Date Title
SE7607496A SE7607496L (sv) 1976-07-01 1976-07-01 Sett for bekempning av virusinfektioner
US05/807,783 US4215113A (en) 1976-07-01 1977-06-20 Method for combating virus infections
DE2728685A DE2728685C2 (de) 1976-07-01 1977-06-25 Arzneimittel zur Bekämpfung von Virusinfektionen
AU26505/77A AU510809B2 (en) 1976-07-01 1977-06-27 Method for combating virus infections
IE1311/77A IE45753B1 (en) 1976-07-01 1977-06-27 Composition and method for combating virus infections
NLAANVRAGE7707235,A NL180068C (nl) 1976-07-01 1977-06-29 Werkwijze ter bereiding van een farmaceutisch preparaat met antivirale werking, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen.
DK288877A DK288877A (da) 1976-07-01 1977-06-29 Fremgangsmade til bekempelse af virusinfektioner
NO772299A NO772299L (no) 1976-07-01 1977-06-29 Fremgangsmaate for bekjempelse av virusinfeksjoner
FI772030A FI772030A (fi) 1976-07-01 1977-06-29
CA281,863A CA1077848A (en) 1976-07-01 1977-06-30 Anti-viral composition containing phosphonoformic acid
GB27464/77A GB1585615A (en) 1976-07-01 1977-06-30 Composition and method for combating virus infections
FR7720100A FR2356424A1 (fr) 1976-07-01 1977-06-30 Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales
LU77666A LU77666A1 (fi) 1976-07-01 1977-06-30
AT0465477A AT369014B (de) 1976-07-01 1977-06-30 Verfahren zur herstellung physiologisch vertraeglicher salze der phosphonoameisensaeure
CH808577A CH641471A5 (de) 1976-07-01 1977-06-30 Verfahren zur herstellung physiologisch vertraeglicher salze der phosphonameisensaeure.
JP7797777A JPS536428A (en) 1976-07-01 1977-07-01 Preventing method of virus infection
BE178982A BE856355A (fr) 1976-07-01 1977-07-01 Procede pour combattre les infections virales
US05/971,931 US4339445A (en) 1976-07-01 1978-12-21 Method for combating virus infection
US06/404,295 US4665062A (en) 1976-07-01 1982-08-02 Method for combating virus infection
SG803/83A SG80383G (en) 1976-07-01 1983-12-20 Composition and method for combating virus infections
HK289/84A HK28984A (en) 1976-07-01 1984-03-29 Composition and method for combating virus infections
US06/793,575 US4771041A (en) 1976-07-01 1985-10-31 Method for combating virus infection
MY125/85A MY8500125A (en) 1976-07-01 1985-12-30 Composition and method for combating virus infections
MX9203635A MX9203635A (es) 1976-07-01 1992-06-26 Composiciones farmaceuticas a base de acido fosfono-formico para combatir infecciones virales.
NL930053C NL930053I2 (nl) 1976-07-01 1993-06-10 Werkwijze ter bereiding van een farmaceutisch preparaat met antivirale werking, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen.
LU88310C LU88310I2 (fr) 1976-07-01 1993-06-16 Foscarnet (Foscavir)
BG098492A BG60834B2 (bg) 1976-07-01 1994-02-18 Фармацевтични състави на базата на фосфономравчена киселина и приложението им
LV960278A LV5791A4 (lv) 1976-07-01 1996-07-18 Metode virusu infekcijas apkarosanai

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607496A SE7607496L (sv) 1976-07-01 1976-07-01 Sett for bekempning av virusinfektioner

Publications (1)

Publication Number Publication Date
SE7607496L true SE7607496L (sv) 1978-01-02

Family

ID=20328354

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7607496A SE7607496L (sv) 1976-07-01 1976-07-01 Sett for bekempning av virusinfektioner

Country Status (22)

Country Link
US (4) US4215113A (fi)
JP (1) JPS536428A (fi)
AT (1) AT369014B (fi)
AU (1) AU510809B2 (fi)
BE (1) BE856355A (fi)
BG (1) BG60834B2 (fi)
CA (1) CA1077848A (fi)
CH (1) CH641471A5 (fi)
DE (1) DE2728685C2 (fi)
DK (1) DK288877A (fi)
FI (1) FI772030A (fi)
FR (1) FR2356424A1 (fi)
GB (1) GB1585615A (fi)
HK (1) HK28984A (fi)
IE (1) IE45753B1 (fi)
LU (2) LU77666A1 (fi)
MX (1) MX9203635A (fi)
MY (1) MY8500125A (fi)
NL (2) NL180068C (fi)
NO (1) NO772299L (fi)
SE (1) SE7607496L (fi)
SG (1) SG80383G (fi)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140049A (en) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid
DK564378A (da) * 1977-12-22 1979-06-23 Astra Laekemedel Ab Fremgangsmaade til fremstilling af amidderivater til bekaempelse af virusinfektioner
DE2926799A1 (de) * 1979-07-03 1981-01-15 Bayer Ag Phosphonoameisensaeurehydrazide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2941384A1 (de) * 1979-10-12 1981-04-23 Bayer Ag, 5090 Leverkusen Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
MC1585A1 (fr) * 1982-02-12 1985-02-22 Ens Bio Logicals Inc Procede de fabrication de compositions antivirales
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
JPH0761814B2 (ja) * 1984-09-10 1995-07-05 三菱化学株式会社 搬送装置
JPS6194925A (ja) * 1984-10-12 1986-05-13 Mitsubishi Chem Ind Ltd 搬送用装置
JPS61217434A (ja) * 1985-03-20 1986-09-27 Mitsubishi Chem Ind Ltd 搬送用装置
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4880619A (en) * 1985-03-11 1989-11-14 Colgate-Palmolive Company Anticalculus oral composition
US4590064A (en) * 1985-03-11 1986-05-20 Colgate-Palmolive Company Anticalculus oral composition
GB8512330D0 (en) * 1985-05-15 1985-06-19 Wellcome Found Antiviral compounds
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
EP0243352A1 (en) * 1985-10-21 1987-11-04 SERGIO, William Method for reducing the risk or probability of infection from the aids virus (htlv-iii/lav/arv)
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US6110901A (en) * 1990-07-03 2000-08-29 American Cyanamid Company Method for treating RNA viral infections by using RNA chain terminators
SE9403861D0 (sv) * 1994-11-09 1994-11-09 Astra Ab Novel medicinal use
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
EP0831842A4 (en) * 1995-06-06 1998-08-19 Univ Southern California METHOD AND MEANS FOR INHIBITING PROPAGATION OF THE CYTOMEGALOVIRUS
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
FI980216A0 (fi) * 1998-01-30 1998-01-30 Bene Pharma Oy Medicin foer behandling av vaorfor
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
DE19940748A1 (de) * 1999-08-27 2001-03-01 Hugo Seinfeld Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide
US20040131622A1 (en) * 2002-07-15 2004-07-08 Board Of Regents Combinations and kits for treating viral infections using immunoconjugates to aminophospholipids
US7790159B2 (en) * 2002-07-15 2010-09-07 Board Of Regents, The University Of Texas System Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
US7611704B2 (en) * 2002-07-15 2009-11-03 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7906115B2 (en) 2002-07-15 2011-03-15 Thorpe Philip E Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7455833B2 (en) * 2002-07-15 2008-11-25 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
US20060166941A1 (en) * 2003-03-14 2006-07-27 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
US7424812B2 (en) 2003-05-16 2008-09-16 Stanton Concepts Inc. Multiple function lock
WO2006119174A1 (en) * 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Method for treating ocular demodex
US20080045482A1 (en) * 2006-01-27 2008-02-21 Adventrx Pharmaceuticals, Inc. Compositions and methods for the treatment of viral infections
US8128968B2 (en) 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
US9006219B2 (en) * 2008-03-12 2015-04-14 Nektar Therapeutics Oligomer-foscarnet conjugates
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
WO2022153334A1 (en) * 2021-01-15 2022-07-21 Jubilant Generics Ltd Transmucosal dosage forms of foscarnet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
US3836650A (en) * 1971-02-25 1974-09-17 Abbott Lab Method for combating marek's disease in poultry
DE2360797C2 (de) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmazeutische Präparate

Also Published As

Publication number Publication date
FR2356424A1 (fr) 1978-01-27
BE856355A (fr) 1978-01-02
ATA465477A (de) 1982-04-15
DE2728685A1 (de) 1978-01-12
CH641471A5 (de) 1984-02-29
FI772030A (fi) 1978-01-02
NL180068C (nl) 1987-01-02
US4665062A (en) 1987-05-12
BG60834B2 (bg) 1996-04-30
US4339445A (en) 1982-07-13
MX9203635A (es) 1992-09-01
LU77666A1 (fi) 1977-10-07
JPS536428A (en) 1978-01-20
LU88310I2 (fr) 1994-05-04
JPS562046B2 (fi) 1981-01-17
NL180068B (nl) 1986-08-01
AU510809B2 (en) 1980-07-17
CA1077848A (en) 1980-05-20
NL930053I2 (nl) 1994-01-03
IE45753B1 (en) 1982-11-17
MY8500125A (en) 1985-12-31
DE2728685C2 (de) 1982-09-16
US4771041A (en) 1988-09-13
HK28984A (en) 1984-04-06
IE45753L (en) 1978-01-01
NL930053I1 (nl) 1993-09-01
FR2356424B1 (fi) 1980-04-18
AT369014B (de) 1982-11-25
NL7707235A (nl) 1978-01-03
NO772299L (no) 1978-04-25
US4215113A (en) 1980-07-29
SG80383G (en) 1984-08-03
GB1585615A (en) 1981-03-11
AU2650577A (en) 1979-01-04
DK288877A (da) 1978-01-02

Similar Documents

Publication Publication Date Title
SE7607496L (sv) Sett for bekempning av virusinfektioner
NL7610172A (nl) Filterstelsel.
FI771364A (fi) Foerfarande vid framstaellning av flerskiktskartong och banbildningsenhet foer utfoerande av foerfarandet.
FR2310149A1 (fr) Eliminateur de buees
DK330477A (da) Katodisk beskyttelsessystem
NL7703681A (nl) Filter.
FI783663A (fi) Fortplantning av virus
SE7704837L (sv) Forfarande for formning av kompoundemnen
FI781820A (fi) Hoelje foer en tallriksventil som kyls av ett cirkulerande kylfluidum foer en foerbraenningsmotor
SE7712855L (sv) Anordning vid brennkammare, foretredesvis for angpannor
SE423727B (sv) Skyddsbeleggning for stalytor
FI811685L (fi) Foerfarande foer isolering av glykoproteinantigener haerledda fraon virus och deras anvaendning vid framstaellning av vaccin
IT1089194B (it) Impianto radiotelefonico
FI762393A (fi) System foer stabilisering av massasuspensionstroemmen i en hydraulisk inloppslaoda i en pappersmaskin
TR19655A (tr) Virus ensektisid terkipleri
DK146086C (da) Filteranlaeg
FI783923A (fi) Befraemjande av tillvaext
FI772951A (fi) Zinkbacitracinkomposition foer anvaendande som fodertillsatsaemne och foerfarande foer framstaellning av den
NO152937C (no) Fremgangsmaate til fremstilling av et attenuert panelukopeni-virus.
SE427241B (sv) Sett for dekantering
SE7704917L (sv) Korrektor
NL7700327A (nl) Preparaat voor metallurgische toepassing.
LV5791A4 (lv) Metode virusu infekcijas apkarosanai
NL7808989A (nl) Integrator.
ES222430Y (es) Filtro.